Hennessy Capital Investment Corp. VII
NASDAQ:HVIIFinancial - Conglomerates
-$0.01 today
- Market cap
- $116.06M
- Beta
- 0.05
- P/E (TTM)
- 61.2
- EPS (TTM)
- $0.17
Volume 10.51M
Average 0.05M
HVII Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Hennessy Capital Investment Corp. VIINASDAQ: HVII
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income remains negative
Q1 FY2026 operating income was -$1.1M, compared with -$489.04K a year earlier. Trailing-twelve-month operating income was -$4.26M.
What to watch
Whether operating income reaches the consensus estimate of $0 (+100.0%) for the fiscal year ending Dec 2026, a step up from the -7525.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.1M+42.2% QoQ
- Last fiscal yearDec 2025
- -$3.66M-7525.5% YoY
- LTMMar 2026
- -$4.26M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -124.3% | +100.0% | +224.3 pp |
| 1 year | -7525.5% | +100.0% | +7625.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (3.66M) USD
- Year-over-year change
- -7525.5%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.66M) | -7525.5% |
| FY2024 | 2024-12-31 | (47.95K) | — |
Operating Income vs competitors
How HVII compares with its peers on the latest reported figures
- HVII's LTM Mar 2026 operating income of -$4.26M is the lowest of the 11 companies compared; the peer median is -$1.85M.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BEAGBold Eagle Acquisition Corp. | LTM Mar 2026 | $268.13K | +151.5% | — | — |
| FY2025 | -$185.83K | — | — | — | |
| LTM Mar 2026 | -$967.64K | -175.5% | — | — | |
OACCOaktree Acquisition Corp. III Life Sciences | LTM Mar 2026 | -$1.21M | — | — | — |
POLEAndretti Acquisition Corp. II | LTM Mar 2026 | -$1.53M | -208.0% | — | — |
| LTM Mar 2026 | -$2.18M | — | — | — | |
| LTM Mar 2026 | -$2.38M | +78.3% | — | — | |
| LTM Mar 2026 | -$2.63M | -452.0% | — | — | |
AACBArtius II Acquisition Inc. Class A Ordinary Shares | LTM Mar 2026 | -$3.62M | — | — | — |
DRDBRoman DBDR Acquisition Corp. II | LTM Mar 2026 | -$3.8M | — | — | — |
| LTM Mar 2026 | -$4.26M | — | — | — | |
| Peer median (excluding HVII) | -$1.85M | -175.5% | — | — | |
Competitors are the stored peer set for HVII. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Gross Margin | — | — |
| Research & Development | 0 | 0 |
| Selling, General & Admin | 47.95K | 3.66M |
| Operating Expenses | 47.95K | 3.66M |
| Depreciation & Amortization | 0 | 0 |
| EBITDA | (47.95K) | (3.66M) |
| EBITDA Margin | — | — |
| Operating Income | (47.95K) | (3.66M) |
| Operating Margin | — | — |
| Interest Income | 0 | 7.34M |
| Interest Expense | 0 | 0 |
| Other Income / Expenses | 0 | 7.34M |
| Income Before Tax | (47.95K) | 3.69M |
| Pre-Tax Margin | — | — |
| Income Tax Expense | 0 | 0 |
| Net Income | (47.95K) | 3.69M |
| Net Margin | — | — |
| EPS (Basic) | (0.00) | 0.15 |
| EPS (Diluted) | (0.00) | 0.15 |
| Weighted Avg Shares | 26.02M | 17.91M |
| Weighted Avg Shares (Diluted) | 26.02M | 17.91M |
Hennessy Capital Investment Corp. VII
NASDAQ:HVII
Intrinsic Alpha fair value
Locked
Current Price
$4.46
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.